HUMAN PAPILLOMA VIRUS
Clinical trials for HUMAN PAPILLOMA VIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Doctors try injecting warts with HPV vaccine
Disease control CompletedThis small pilot study explored whether injecting the Gardasil 9 vaccine directly into genital warts could help treat them. Two adult participants with multiple warts received the injections and were monitored for changes. The goal was to see if this method could reduce wart size…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC
-
Could a simple swab at home replace a Doctor's visit for cervical cancer screening?
Diagnosis CompletedThis study tested whether a self-collected vaginal swab kit is as accurate as a doctor-collected cervical swab for detecting HPV, the virus that causes cervical cancer. Researchers compared the results from 222 women who used the home kit with the results from their standard clin…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Apr 02, 2026 00:57 UTC
-
Could a simple At-Home swab revolutionize cervical cancer screening?
Diagnosis CompletedThis study tested whether a new type of HPV test, which can be done on a sample a woman collects herself at home, can accurately identify which women need to see a doctor for further checks. It enrolled 294 women aged 30-69 who were already scheduled for cervical screening. The g…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: George Washington University • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
Local champions vs. outside experts: which works better for vaccine talks?
Prevention CompletedThis study tested two ways to train clinic staff on how to better communicate with parents about the HPV vaccine. Researchers compared training delivered by an outside expert to training delivered by a respected 'vaccine champion' from within the clinic's own healthcare system. T…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Prevention
Last updated Mar 27, 2026 12:41 UTC
-
Research sheds light on hidden HPV risk in key population
Knowledge-focused CompletedThis study aimed to understand how common high-risk anal HPV infections and abnormal cell changes are in men who have sex with men (MSM). Researchers compared two groups: HIV-negative men using medication to prevent HIV (PrEP) and men already living with HIV. They collected infor…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Apr 02, 2026 00:56 UTC
-
Scientists track HPV vaccine protection in High-Risk women
Knowledge-focused CompletedThis study examines how well the HPV vaccine protects against infections that can lead to cervical cancer over many years. Researchers followed 3,127 Rwandan women aged 18-28, including those living with and without HIV, to compare infection rates between vaccinated and unvaccina…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Can a phone app change Women's health knowledge?
Knowledge-focused CompletedThis study tested whether a mobile app providing education about HPV and breast cancer could improve women's knowledge and their attitudes toward getting screened. Researchers compared a group of 70 women who used the app to a group that did not. The goal was to see if the app ma…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: Ataturk University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Could thousands of women skip unnecessary cervical scans?
Knowledge-focused CompletedThis study followed over 46,000 women in the Netherlands to understand their risk of developing cervical cancer. It focused on women who tested positive for HPV and had only mild, low-grade abnormalities in their cervical screening tests. The goal was to see if the cancer risk fo…
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: Gynaecologisch Oncologisch Centrum Zuid • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC